Eli Lilly Program Manager interview questions 2026

TL;DR

Eli Lilly's Program Manager interviews rigorously assess a candidate's command of structured execution, cross-functional influence in complex scientific environments, and an ingrained understanding of regulatory compliance. Success requires demonstrating meticulous planning and risk mitigation within GxP frameworks, not merely agile project management. The process filters for candidates who can navigate multi-year drug development lifecycles with precision and authority.

Who This Is For

This guide is for experienced Program Managers and Senior Project Managers targeting Eli Lilly, particularly those transitioning from adjacent regulated industries like medical devices, aerospace, or biotech, or seasoned professionals within pharma aiming for a step up.

It is not for software product managers seeking a direct translation of their experience, nor for entry-level candidates. The insights herein are tailored for individuals who understand the gravity of managing projects where patient safety and regulatory adherence are paramount, and who are prepared to articulate their impact in a highly structured, scientifically driven corporate environment.

What type of Program Manager questions does Eli Lilly ask?

Eli Lilly prioritizes demonstrated command of structured execution and risk management over abstract strategic thinking, probing candidates for their ability to deliver complex projects within stringent regulatory frameworks. In a Q3 debrief for a Senior Program Manager role, the hiring manager pushed back on a candidate who articulated a strong "vision" but provided vague answers regarding phase-gate reviews, budget reconciliation in a multi-year R&D context, and specific mitigation strategies for clinical trial delays.

The problem wasn't the candidate's ambition; it was their lack of granular operational rigor. Eli Lilly isn't looking for someone who can merely sketch a roadmap; they demand an architect who can detail the structural integrity, material specifications, and regulatory approvals for every beam and pillar.

The core of Eli Lilly's assessment revolves around your capacity to manage projects with high stakes and long timelines, where failure carries not just financial implications, but potential patient harm or significant regulatory penalties. They will ask about your experience with GxP (Good Practice) principles – GCP (Clinical Practice), GLP (Laboratory Practice), GMP (Manufacturing Practice) – and how these inform your program planning, execution, and documentation. Expect questions on how you manage scope creep in multi-year drug development, how you integrate regulatory submissions into your project plan, and how you ensure data integrity across various stages.

It’s not about agile sprints, but about disciplined phase progression and rigorous change control. The interviewer wants to understand your default operating model for identifying, assessing, and mitigating risks that could derail a clinical trial or delay a drug launch, not just standard project risks. The signal they are looking for is an inherent appreciation for the constraints of a regulated environment, not a desire to bypass them.

Your responses must reflect a deep appreciation for process and documentation, not just outcomes. In one debrief, a candidate described a successful project where they "cut through red tape" to accelerate delivery. While this might be celebrated in a startup, it raised significant red flags at Eli Lilly.

The hiring committee questioned whether the candidate understood that "red tape" often represents critical patient safety and regulatory compliance safeguards. The insight here is: the problem isn't your drive for efficiency; it's your judgment signal regarding the non-negotiable elements of pharmaceutical development. Eli Lilly values innovation within a framework of strict adherence, not innovation that challenges the framework itself. Therefore, prepare to discuss specific examples where you navigated complex regulatory landscapes, managed intricate documentation requirements, and ensured audit readiness, rather than merely delivering ahead of schedule.

How does Eli Lilly assess cross-functional leadership for Program Managers?

Eli Lilly evaluates a Program Manager's ability to drive complex initiatives across disparate scientific, clinical, and commercial teams, not just orchestrate software sprints, requiring influence without direct authority.

In a recent debrief, a hiring manager explicitly stated why a candidate with strong FAANG tech PM experience didn't progress: "They spoke of 'stakeholder management' in terms of engineering dependencies, but couldn't articulate how they'd align a principal research scientist, a clinical operations lead, and a manufacturing director, each with distinct metrics and timelines, on a critical path change." The candidate lacked experience with matrixed, non-hierarchical influence in a scientific context where persuasion often trumps mandate.

Program Managers at Eli Lilly operate within a highly matrixed organization where direct reporting lines are less common than dotted ones across different functional areas, therapeutic areas, and global regions. Your ability to lead here is a function of your technical credibility, your mastery of the process, and your capacity to build consensus among highly specialized experts.

Interviewers will probe for specific examples of how you have influenced senior scientists to prioritize certain experiments, convinced clinical trial managers to adopt new data collection methods, or aligned marketing teams on product launch timing despite competing internal priorities. They are looking for evidence of sophisticated negotiation skills, conflict resolution within a professional scientific context, and the ability to articulate trade-offs in a language that resonates with diverse stakeholders. It's not about being charismatic; it's about being competent and credible.

The insight here is that influence at Eli Lilly is built on technical understanding and a demonstrated ability to navigate complex organizational politics, not just generic communication skills. During a Hiring Committee debate, a candidate was praised for successfully mediating a long-standing disagreement between toxicology and pharmacology teams regarding a drug candidate's safety profile. The candidate didn't impose a solution; they facilitated a data-driven discussion, brought in external experts, and helped the teams co-create a revised testing protocol that satisfied both departments and met regulatory expectations.

This was a clear signal of effective leadership in a critical, high-stakes scenario. The committee’s judgment was that this demonstrated a deep understanding of influencing highly specialized professionals. Therefore, your "not X, but Y" is: Not "motivating a dev team through stand-ups," but "aligning research scientists, regulatory experts, and manufacturing leads through data-backed persuasion and structured problem-solving."

What are Eli Lilly's expectations for Program Managers regarding risk and compliance?

Program Managers at Eli Lilly are expected to be architects of risk mitigation and champions of compliance, not merely project schedulers, integrating these principles into every phase of program design and execution.

In a Hiring Committee discussion concerning a candidate for a new drug development program, a key point of contention was the candidate's generalized approach to "identifying and tracking risks." While they could list potential issues, their proposed solutions lacked specific GxP implications or a multi-layered mitigation strategy tailored to regulatory scrutiny. The committee judged this as a fundamental gap: risk is not a side-effect to manage; it's a foundational constraint to design around within the pharmaceutical industry.

Eli Lilly operates in one of the most heavily regulated industries globally. For Program Managers, this means that every decision, every process, and every deliverable must be viewed through the lens of regulatory compliance (e.g., FDA, EMA, PMDA) and patient safety. Interviewers will assess your understanding of how GxP regulations impact program timelines, resource allocation, and documentation requirements.

Expect questions about your experience in developing risk management plans that are not just theoretical, but actionable and auditable. They want to see how you proactively identify potential non-compliance issues, design preventative measures, and establish robust monitoring systems. This isn't about filling out a risk register; it's about embedding a compliance mindset into the fabric of your program.

Your examples must demonstrate a sophisticated understanding of how to balance aggressive timelines with non-negotiable compliance obligations. In one scenario I observed, a candidate presented a compelling case study on accelerating a manufacturing process. However, when pressed on the regulatory re-validation steps required for such a change and the potential impact on product stability data, the candidate faltered.

This signaled a critical lack of appreciation for the integrated nature of compliance. The insight is clear: your problem-solving must demonstrate an understanding that regulatory adherence is not a separate task but an inherent quality attribute of every output. The "not X, but Y" here is: Not "identifying roadblocks and finding workarounds," but "proactively engineering resilience against regulatory non-compliance or clinical trial failure through structured GxP-compliant processes and documentation." You must demonstrate that you build programs to withstand regulatory scrutiny from day one, not simply react to it.

What is the typical interview process and timeline for an Eli Lilly Program Manager role?

The Eli Lilly Program Manager interview process is rigorous and comprehensive, typically spanning 6-8 weeks and involving 5-7 distinct rounds designed to probe both technical depth and cultural fit in a highly structured, compliance-driven environment. This extended timeline is a deliberate filter, ensuring candidates possess not only the requisite skills but also the resilience and commitment necessary for long-term pharmaceutical programs.

The typical progression begins with an initial recruiter screen (30 minutes) to assess foundational qualifications and cultural alignment. This is followed by a hiring manager interview (45-60 minutes) focused on your leadership style, program management philosophy, and direct experience relevant to the specific role.

Next, candidates usually undergo 2-3 peer interviews (each 45-60 minutes) with current Program Managers or Senior Project Leaders, evaluating technical acumen, collaboration skills, and problem-solving approaches within Eli Lilly's operational context. These rounds often include behavioral questions centered on navigating ambiguity, managing complex stakeholders, and handling setbacks in regulated environments.

Following successful peer interactions, a cross-functional leader interview (60 minutes) assesses your ability to influence and lead without direct authority across scientific, clinical, or commercial functions. This is a critical stage where your matrix leadership capabilities are scrutinized. The final stage is typically an executive loop (1-2 interviews, 45-60 minutes each) with senior leadership, focusing on strategic thinking, leadership presence, and alignment with Eli Lilly's broader objectives and values.

Throughout this process, candidates may be asked to complete a case study or prepare a presentation on a relevant program management challenge. Average base salaries for a Senior Program Manager at Eli Lilly can range from $150,000 to $220,000, depending on location, specific responsibilities, and years of relevant experience, with additional bonuses and equity. The length of the process isn't a lack of efficiency; it's a deliberate filter for commitment and endurance in an industry defined by multi-year project lifecycles and high stakes. It's not "speed to hire," but "precision of fit."

How should Program Managers present their experience in a biotech/pharma context?

Program Managers must frame their experience through the lens of GxP adherence, phase-gate delivery, and complex stakeholder management inherent in drug development, not generic agile methodologies, to resonate with Eli Lilly's context. In a debrief, a candidate’s detailed description of "scrum ceremonies" and "sprint velocity" fell flat because it didn’t translate to the clinical trial context or the rigorous phase-gate structure of pharmaceutical development. The insight is that your narrative must demonstrate an understanding of the industry's unique cadence and constraints, not just an application of universal project management tenets.

When discussing your past programs, explicitly connect your actions to regulatory requirements and patient outcomes. For instance, instead of stating, "I managed a large project," articulate, "I led a multi-site clinical trial program from Phase I to Phase III, ensuring adherence to GCP guidelines and successfully navigating multiple FDA audits." Highlight your experience with quality management systems (QMS), document control, and change management processes specifically designed for regulated environments.

Emphasize how your decisions impacted compliance, data integrity, and ultimately, patient safety. Eli Lilly is not just building software; it is developing life-changing medicines, and your experience must reflect an appreciation for this profound difference.

Furthermore, emphasize your ability to manage long-term projects with evolving scientific data and regulatory landscapes. Drug development isn't a linear process; it's iterative, often requiring significant adjustments based on trial results, safety signals, or new scientific insights.

Provide examples of how you adapted program plans, managed scope changes, and re-allocated resources while maintaining regulatory compliance and scientific rigor. Your "not X, but Y" needs to be clear: Not "sprint velocity and feature delivery," but "clinical trial phase progression, regulatory submission readiness, and patient safety monitoring." This demonstrates that you grasp the unique challenges and responsibilities of program management within a highly regulated, scientifically complex domain like Eli Lilly.

Preparation Checklist

Deeply research Eli Lilly's recent drug pipeline, therapeutic areas, and public statements on innovation and compliance. Understand the company's strategic priorities.

Review GxP regulations (GCP, GMP, GLP) and be prepared to discuss how you've applied these principles in past roles. This is non-negotiable.

Practice articulating your experience using the STAR method, focusing on situations where you navigated complex regulatory environments, managed scientific stakeholders, and mitigated high-stakes risks.

Develop specific, quantifiable examples of how you've driven cross-functional alignment and influenced without direct authority in matrixed organizations.

Prepare questions for your interviewers that demonstrate your understanding of Eli Lilly's business model, regulatory challenges, and program management culture.

Work through a structured preparation system (the PM Interview Playbook covers specific Eli Lilly-relevant frameworks for GxP scenarios and cross-functional alignment with real debrief examples).

Refine your "why Eli Lilly" narrative, connecting your personal and professional values to the company's mission in a genuine, informed way.

Mistakes to Avoid

Underestimating Regulatory Impact:

BAD Example: "I managed a software project where we occasionally missed deadlines, but we always caught up." (Fails to acknowledge the gravity of regulatory non-compliance or patient safety implications in pharma.)

GOOD Example: "I led a cross-functional team in a GxP environment, implementing a new documentation system that reduced critical audit findings by 15% across all clinical sites, directly improving our regulatory posture and data integrity for submissions." (Demonstrates specific understanding of regulatory impact and compliance.)

Generic "Leadership" Without Specific Influence Tactics in a Matrix:

BAD Example: "I'm a great communicator and can motivate any team to achieve targets." (Too general; doesn't address the unique challenges of influencing highly specialized, often non-hierarchical, scientific and clinical teams.)

GOOD Example: "In a recent R&D program, I successfully aligned principal research scientists and manufacturing engineers on a critical process change by presenting data-backed trade-offs, facilitating a consensus workshop, and securing buy-in from key opinion leaders, despite initial departmental friction over resource allocation." (Highlights specific, nuanced influence tactics relevant to a complex matrix.)

Failing to Structure Problem-Solving for Long-Term, High-Stakes Projects:

BAD Example: "For a new product, I'd quickly prototype a solution, get user feedback, and iterate rapidly." (Applicable in some tech contexts, but wholly inappropriate for drug development where rapid, informal iteration on safety-critical elements is a non-starter.)

GOOD Example: "For a critical drug development pathway, my approach involves a multi-stage risk assessment matrix, including regulatory impact, patient safety, and market access considerations. I establish pre-defined phase-gate criteria with clear go/no-go decisions and robust mitigation strategies at each stage to ensure long-term program integrity and compliance." (Shows a structured, high-stakes, long-term planning mindset.)

FAQ

Is a scientific background mandatory for Eli Lilly Program Managers?

No, a scientific degree is not strictly mandatory, but a demonstrated capacity to quickly understand complex scientific and regulatory contexts is critical. Candidates from non-scientific backgrounds must prove their ability to grasp technical nuances, navigate a GxP environment, and effectively communicate with scientific experts, often through prior experience in regulated industries.

How important is agility in Eli Lilly's Program Manager roles?

Agility at Eli Lilly is interpreted through the lens of adaptability and robust change management within strict regulatory boundaries, not rapid software iteration. While project plans must be flexible to scientific discoveries or clinical trial results, changes require meticulous documentation, impact assessment, and often regulatory approval, contrasting sharply with typical tech agile methodologies.

What salary range can a Senior Program Manager expect at Eli Lilly?

A Senior Program Manager at Eli Lilly can typically expect a base salary between $150,000 and $220,000, influenced by geographic location (e.g., Indianapolis vs. Boston), specific program scope, and extensive experience. This range does not include performance bonuses, stock options, or other benefits, which can significantly increase total compensation.

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.